logo

For the Inventor, By the Inventor

Seoul, South Korea

Viromed Co., Ltd.


USPTO Granted Patents = 17



Trademarks = 2

Forward Citations = 111

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Jong-Mook Kim (8 out of 13 patents)

silverMedal Woong Hahn (5 out of 6 patents)

bronzeMedal Sujeong Kim (4 out of 15 patents)

4.  Sunyoung Kim (3 out of 37 patents)

5.  Eun-Jin Park (3 out of 7 patents)

6.  Song Xu (2 out of 6 patents)

7.  Seong-Hyun Ho (2 out of 3 patents)

8.  Seung Shin Yu (1 out of 6 patents)

9.  Jin-A Chae (1 out of 2 patents)

10.  Mi Rim Jin (1 out of 6 patents)

11.  Hwa-Jun Lee (1 out of 4 patents)

12.  Chang-Yuil Kang (1 out of 10 patents)

13.  Jun-tae Lee (1 out of 5 patents)

14.  Sun-Young Chang (1 out of 29 patents)

15.  Sun-Young Kim (1 out of 44 patents)


17 patents:

1. 10058583 - Herbal compositions for treating neurological diseases and improving memory impairment (2018-08-28),
2. 9963493 - Gene therapy for diabetic neuropathy using an HGF isoform (2018-05-08),
3. 9404090 - Adenovirus producing novel cell line and the use thereof (2016-08-02),
4. 9131722 - [object Object] (2015-09-15),
5. 8716446 - Biopolymer conjugates comprising an interleukin-11 analog (2014-05-06),
6. 8445268 - Her-2/neu DNA vaccine having anti-cancer activity (2013-05-21),
7. 8394426 - Composition comprising an extract of hardy kiwi for preventing or treating baldness disorders or seborrheic skin disorders (2013-03-12),
8. 8389492 - Lyophilized DNA formulations for enhanced expression of plasmid DNA (2013-03-05),
9. 8338385 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2012-12-25),
10. 8106158 - Compositions and methods for fusion protein separation (2012-01-31),
11. 8105575 - Expression vectors with improved safety (2012-01-31),
12. 7838505 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-11-23),
13. 7812146 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-10-12),
14. 7745174 - Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor (2010-06-29),
15. 7585943 - Compositions and methods for fusion protein separation (2009-09-08),
Viromed Co., Ltd. is a leading biotech company specializing in the research, development, and commercialization of innovative gene therapy solutions. With a focus on advancing personalized medicine, Viromed is dedicated to improving patient outcomes through cutting-edge genetic technologies. Established in 2006, the company has a proven track record of success in developing viral vectors for gene delivery and gene editing applications. Viromed's commitment to quality, safety, and efficacy has positioned it as a trusted partner in the biopharmaceutical industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#219 in Seoul

#681 in South Korea

#34,854 in the World

...
Seoul, South Korea

Viromed Co., Ltd.

Forward Citations = 111

43 inventors:

goldMedal Jong-Mook Kim (8 out of 13 patents)

silverMedal Woong Hahn (5 out of 6 patents)

bronzeMedal Sujeong Kim (4 out of 15 patents)

4.  Sunyoung Kim (3 out of 37 patents)

5.  Eun-Jin Park (3 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…